Rapid treatment with CeleCor Therapeutics' investigational heart-attack drug, zalunfiban, resulted in higher levels of blood flow to the heart and an approximately 21% reduction in a patient's risk of ...

With numerous editions of Productronica behind it, EIIT — a Controlar company — will present its renewed series of in-line ...

In 2026, the barrier to entry for quality design work has never been lower. Many modern free UI/UX design tools now include AI assistants that generate layouts from text prompts, ...

Japan's Innovation Center of NanoMedicine reports on a new stealth coating for tiny medicine-carrying particles that doesn't ...

Baystreet.ca News Commentary – Gold mining equities have quietly outperformed the S&P 500 over the past decade despite limited investor participation[1], while companies ...

CuraSen Therapeutics, Inc., a biopharmaceutical company developing drug candidates with broad applicability in neurodegenerative and neuropsychiatric diseases, today announced encouraging results from ...